FDA Inspection 1323212 — Linde Inc.
The FDA completed an inspection of Linde Inc. on June 11, 2026 in Ashtabula, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ashtabula, OH (United States)